|128.17||+0.1300||+0.10%||Vol 793.59K||1Y Perf 13.73%|
|Jun 15th, 2021 16:03 DELAYED|
|- -||- -%|
|Target Price||146.80||Analyst Rating||Moderate Buy 2.04|
|Potential %||14.54||Finscreener Ranking||★★★★ 54.83|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 58.40|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★★ 70.65|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★★+ 48.39|
|Market Cap||16.74B||Earnings Rating||Sell|
|Price Range Ratio 52W %||63.00||Earnings Date||22nd Jul 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||22nd Jul 2021|
|Estimated EPS Next Report||2.88|
|EPS Growth Next 5 Years %||26.50|
|Avg. Weekly Volume||796.08K|
|Avg. Monthly Volume||1.09M|
|Avg. Quarterly Volume||1.16M|
Quest Diagnostics Incorporated (NYSE: DGX) stock closed at 128.17 per share at the end of the most recent trading day (a 0.1% change compared to the prior day closing price) with a volume of 794.35K shares and market capitalization of 16.74B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 49000 people. Quest Diagnostics Incorporated CEO is Stephen H. Rusckowski.
The one-year performance of Quest Diagnostics Incorporated stock is 13.73%, while year-to-date (YTD) performance is 7.55%. DGX stock has a five-year performance of 67.06%. Its 52-week range is between 103.26 and 142.8, which gives DGX stock a 52-week price range ratio of 63.00%
Quest Diagnostics Incorporated currently has a PE ratio of 9.70, a price-to-book (PB) ratio of 2.29, a price-to-sale (PS) ratio of 1.51, a price to cashflow ratio of 7.00, a PEG ratio of 2.32, a ROA of 13.41%, a ROC of 17.69% and a ROE of 28.11%. The company’s profit margin is 18.25%, its EBITDA margin is 28.40%, and its revenue ttm is $10.33 Billion , which makes it $85.02 revenue per share.
Of the last four earnings reports from Quest Diagnostics Incorporated, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $2.88 for the next earnings report. Quest Diagnostics Incorporated’s next earnings report date is 22nd Jul 2021.
The consensus rating of Wall Street analysts for Quest Diagnostics Incorporated is Moderate Buy (2.04), with a target price of $146.8, which is +14.54% compared to the current price. The earnings rating for Quest Diagnostics Incorporated stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Quest Diagnostics Incorporated has a dividend yield of 1.94% with a dividend per share of $2.48 and a payout ratio of 21.00%.
Quest Diagnostics Incorporated has a Neutral technical analysis rating based on Technical Indicators (ADX : 7.39, ATR14 : 2.25, CCI20 : -65.61, Chaikin Money Flow : -0.19, MACD : -1.06, Money Flow Index : 64.82, ROC : -3.31, RSI : 42.94, STOCH (14,3) : 25.79, STOCH RSI : 1.00, UO : 39.69, Williams %R : -74.21), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Quest Diagnostics Incorporated in the last 12-months were: Catherine T. Doherty (Option Excercise at a value of $3 883 652), Catherine T. Doherty (Sold 66 928 shares of value $7 653 067 ), Daniel C. Stanzione (Sold 11 223 shares of value $1 417 459 ), Gail R. Wilensky (Option Excercise at a value of $352 391), Gail R. Wilensky (Sold 6 111 shares of value $770 120 ), Mark J. Guinan (Option Excercise at a value of $5 437 591), Mark J. Guinan (Sold 81 756 shares of value $9 840 673 ), Michael E. Prevoznik (Option Excercise at a value of $5 054 912), Michael E. Prevoznik (Sold 88 093 shares of value $11 294 916 ), Michael J. Deppe (Option Excercise at a value of $598 244), Michael J. Deppe (Sold 10 450 shares of value $1 306 250 ), Stephen H. Rusckowski (Option Excercise at a value of $19 420 720), Stephen H. Rusckowski (Sold 291 997 shares of value $35 039 640 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.